1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200–1205.
2. Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 2010;8:63–72.
3. Chung SY, Jung SY, Shin JY, Park BJ. The role of the KIDS for enhancing drug safety and risk management in Korea. J Korean Med Assoc 2012;55:861–868.
4. Oh IH, Yoon SJ, Kim EJ. The burden of disease in Korea. J Korean Med Assoc 2011;54:646–652.
6. Zhou L, Maviglia SM, Mahoney LM, et al. Supratherapeutic dosing of acetaminophen among hospitalized patients. Arch Intern Med 2012;172:1721–1728.
8. Kim SY, Choi MY, Shin SS, et al. NECA's handbook for clinical practice guideline development. Seoul: National Evidence-based Healthcare Collaborating Agency, 2015.
10. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296–1310.
11. Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol 2016;4:131–142.
13. Kobata Y, Yajima H, Yamao J, Tanaka Y, Fukui H, Takakura Y. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study. Mod Rheumatol 2009;19:629–636.
14. Artnak KE, Wilkinson SS. Fulminant hepatic failure in acute acetaminophen overdose. Dimens Crit Care Nurs 1998;17:135–144.
15. Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 2010;31:1064–1076.
16. Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004;40:6–9.
18. Kuffner EK, Dart RC. Acetaminophen use in patients who drink alcohol: current study evidence. Am J Manag Care 2001;7 Suppl 19:S592–S596.
19. Bartels S, Sivilotti M, Crosby D, Richard J. Are recommended doses of acetaminophen hepatotoxic for recently abstinent alcoholics? A randomized trial. Clin Toxicol (Phila) 2008;46:243–249.
20. Kuffner EK, Green JL, Bogdan GM, et al. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study. BMC Med 2007;5:13.
21. Dart RC, Green JL, Kuffner EK, Heard K, Sproule B, Brands B. The effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol - a randomized study. Aliment Pharmacol Ther 2010;32:478–486.
22. Temple AR, Benson GD, Zinsenheim JR, Schweinle JE. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Clin Ther 2006;28:222–235.
23. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol 2019;70:1222–1261.
24. Cebollero-Santamaria F, Smith J, Gioe S, et al. Selective outpatient management of upper gastrointestinal bleeding in the elderly. Am J Gastroenterol 1999;94:1242–1247.
25. Lee HL, Han DS, Kim JB, et al. Importance of age and other risk factors in NSAID-induced gastropathy. Korean J Gastroenterol 2004;44:246–251.
27. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993;153:1665–1670.
28. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769–772.
29. Kryger M, Roth R, Dement W. Principle and practice of sleep medicine. 4th ed. Philadelphia: Elsevier, 2005.
31. Rummans TA, Davis LJ Jr, Morse RM, Ivnik RJ. Learning and memory impairment in older, detoxified, benzodiazepine-dependent patients. Mayo Clin Proc 1993;68:731–737.
32. Díaz-Gutiérrez MJ, Martínez-Cengotitabengoa M, Sáez de Adana E, et al. Relationship between the use of benzodiazepines and falls in older adults: a systematic review. Maturitas 2017;101:17–22.
33. Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine use in older adults: dangers, management, and alternative therapies. Mayo Clin Proc 2016;91:1632–1639.
34. Korean Neuropsychiatric Association. Textbook of neuropsychiatry. 3rd ed. Seoul: Imis Company, 2017.
35. Hollister LE. Interactions between alcohol and benzodiazepines. Recent Dev Alcohol 1990;8:233–239.
37. Park HY, Shon HS, Kwon JW. Reviews on the current status and appropriate management of polypharmacy in South Korea. Korean J Clin Pharm 2018;28:1–9.
39. Hao Q, Hu X, Xie L, et al. Prevalence of sarcopenia and associated factors in hospitalised older patients: a cross-sectional study. Australas J Ageing 2018;37:62–67.
40. Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med 2012;28:173–186.